CNS Pharmaceuticals Inc. (CNSP)
NASDAQ · Healthcare
CNS Pharmaceuticals Inc. Total Liabilities 2020–2025
CNS Pharmaceuticals Inc. annual total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- CNS Pharmaceuticals Inc. total liabilities as of December 31, 2025: 4.1M, a 62.46% increase year-over-year.
- CNS Pharmaceuticals Inc. total liabilities for 2025 were 4.1M, a 62.46% increase from 2024.
- CNS Pharmaceuticals Inc. total liabilities for 2024 were 2.5M, a 58.84% decrease from 2023.
- CNS Pharmaceuticals Inc. total liabilities for 2023 were 6.1M, a 24.65% increase from 2022.
- CNS Pharmaceuticals Inc. total liabilities for 2022 were 4.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| CNS Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $3 |
| 2023 | $6 |
| 2022 | $5 |
| 2021 | $3 |
| 2020 | $2 |
CNS Pharmaceuticals Inc. Total Liabilities — FAQ
CNS Pharmaceuticals Inc. (CNSP) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CNSP's total liabilities history?
The chart and table above show CNS Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.